Core Scientific, Inc. provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment. In addition, the company provides electrical power, repair, and other infrastructure services to operate, maintain, and earn digital assets; and sells mining equipment to customers. Core Scientific, Inc. was founded in 2017 and is headquartered in Dover, Delaware.

Core Scientific, Inc.

Сильный индекс, значительно вырос. Быки крепко уверены в своих позициях.

Strong index, significantly up. The bulls are very confident in their positions.

Слабый индекс, незначительно упал. Рынок не поддерживает быков.

Weak index, slightly down. The market does not support the bulls.

Сильный индекс, значительно упал. Отток средств из лонгов резко увеличился и находится на высоком уровне.

Strong index, significantly down. The outflow of funds from longs has increased sharply and is at a high level.

(RTTNews) - On Friday, Core Scientific, Inc. (CORZ), a digital infrastructure company, announced the appointment of Jay Elms as the Chief Commercial Officer of the company.
In this role, Elms will take charge in growing customer relationships and overseeing the customer experience from initial engagement through deployment.
Elms has more than 20 years of experience in sales and commercial leadership. Most recently, he was Senior Vice President of Global Sales at CyrusOne. Before that, he spent nearly seven years as Vice President of Global Sales at NTT Global Data Centers Americas, where he worked with large hyperscale and wholesale customers. Earlier, he held sales leadership roles at View, Schneider Electric, and Siemens.
In the after hours on the Nasdaq, the shares were trading 1.21 percent up at $17.55, after closing Friday's trading 4.30 percent down.

Core Scientific Appoints Jay Elms As Chief Commercial Officer

Key Points
The transaction was valued at $134,330.
The purchase increased the director's direct equity holdings by 3%.
The acquisition was executed directly by the reporting owner, bringing his total direct position to approximately 260,000 shares.
Eric Stanton Weiss, a Director at Core Scientific (NASDAQ:CORZ), purchased 7,000 shares of common stock on Aug. 18, 2026, according to a recent SEC Form 4 filing.
Transaction summary
Transaction value
$134,330
Shares purchased
7,000
Post-transaction shares (directly held)
259,262
Post-transaction value
$4.9 million
Transaction value based on SEC Form 4 weighted average purchase price ($19.19); post-transaction value based on Aug. 18, 2026, market close ($18.85).
Key questions
What was the execution context for this purchase?
The shares were acquired in multiple transactions at prices ranging from $18.78 to $19.59, resulting in a weighted-average cost of $19.19 per share.
How does this purchase affect the director's total stake?
Weiss now directly holds 259,262 shares of common stock, representing an 0.08% ownership interest in the company.
What are the core business operations of the company?
Core Scientific is a North American enterprise primarily engaged in digital asset mining and providing colocation services for distributed ledger technology, operating specialized data centers to process blockchain transactions.
How has the stock performed leading up to this transaction?
The company's shares were priced at $18.72 as of the Aug. 19, 2026, market close, following a period where the stock delivered a 30% return over the 12 months ending on the transaction date.
Company Overview
Share Price (as of market close 2026-08-19)
$18.72
Market Capitalization
$6 billion
Revenue (TTM)
$440.3 million
Net Income (TTM)
-$1.6 billion
Company Snapshot
Core Scientific operates digital asset mining facilities and provides colocation services for distributed ledger technology infrastructure, generating revenue through proprietary cryptocurrency mining operations and hosting services for third-party blockchain network participants.
The company generates revenue through two primary channels: direct digital asset mining conducted within its owned and operated data centers, and colocation services that leverage its specialized computing hardware and infrastructure to support external clients' blockchain operations.
Core Scientific serves enterprise clients and digital asset participants who require high-performance computing infrastructure, targeting organizations seeking reliable, scalable hosting solutions for blockchain network operations and cryptocurrency mining.
Core Scientific operates a substantial North American infrastructure platform with 325 employees and $6 billion in market capitalization, positioning itself as a significant player in the digital asset mining and blockchain infrastructure sectors. The company's competitive advantage derives from its owned-and-operated data centers, equipped with specialized computing hardware optimized for blockchain transaction processing and digital asset mining. With TTM revenue of $440.3 million, Core Scientific has established a material revenue base while navigating the capital-intensive and volatile digital asset market through diversified revenue streams combining proprietary mining operations with third-party colocation services.
What this transaction means for investors
The Core Scientific stock price has performed well over the last year, climbing 34.4%. In comparison, the S&P 500 is up 18.1% over the same period. With a strong performance like that, it may be common to see some executives sell shares. But an insider buying into a rising stock price is a bullish signal for shareholders, as it indicates that Weiss expects shares to keep climbing. His purchase of 7,000 shares adds to his substantial holdings that now total nearly 260,000.
In addition to Weiss's purchase, another bullish signal for Core Scientific's stock price is how analysts view the company. Out of 18 who cover the stock, 94% rate it a buy, while 6% rate it a hold, according to CNN. From that group, the median one-year price target is $36, representing a gain of 92.2% from today's price ($18.73). The highest price target of $55 is even more bullish, representing a 193.6% gain. And even the lowest price target, $28, would still represent a gain of nearly 50%. With a rising stock price, insider buying, and bullish analyst outlooks, there are a lot of positive signals about where the Core Scientific stock price could head next.
Should you buy stock in Core Scientific right now?
Before you buy stock in Core Scientific, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Core Scientific wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $421,997!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,413,876!*
Now, it’s worth noting Stock Advisor’s total average return is 978% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 8, 2026.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Core Scientific Director Purchases 7,000 Shares

Key Points
The sale was valued at approximately $110,000.
This acquisition increased her direct equity holdings in the company by 9%.
The Core Scientific stock price has steadily outperformed the S&P 500 over the last year.
Elizabeth Crain, a Director at Core Scientific (NASDAQ:CORZ), executed a direct purchase of 6,000 shares of common stock on Aug. 20, 2026, according to a SEC Form 4 filing.
Transaction summary
Transaction value
$109,980
Shares purchased (directly held)
6,000
Post-transaction shares (directly held)
71,348
Post-transaction value
$1.3 million
Transaction value based on SEC Form 4 weighted average purchase price ($18.33); post-transaction value based on Aug. 20, 2026, market close ($18.39).
Key questions
What were the execution details of this purchase?
The shares were acquired in multiple transactions at prices ranging from $18.27 to $18.34, resulting in a weighted average execution price of $18.33 per share.
How does this transaction affect Crain's total ownership?
Following the purchase of 6,000 shares, Crain holds 71,348 shares directly, which represents her entire reported beneficial ownership stake in the company.
What is the current market context for Core Scientific?
Core Scientific is a North American enterprise engaged in digital asset mining and colocation services, with a market capitalization of $5.5 billion and a stock price of $17.81 as of the Aug. 21, 2026, market close.
What is the scale of the director's current equity position?
The total post-transaction holding of 71,348 shares corresponds to an insider ownership percentage of 0.02%.
Company Overview
Share Price (as of market close 2026-08-21)
$17.81
Market Capitalization
$5.5 billion
Revenue (TTM)
$440.3 million
Net Income (TTM)
-$1.6 billion
Company Snapshot
Core Scientific operates digital asset mining facilities and provides colocation services for blockchain infrastructure, generating revenue through proprietary cryptocurrency mining operations and hosting services for distributed ledger technology participants.
The company's business model centers on leveraging owned and operated data centers equipped with specialized computing hardware to process blockchain transactions in exchange for digital asset rewards, while simultaneously monetizing excess capacity through colocation and hosting services to enterprise clients.
Core Scientific serves enterprise customers and digital asset participants requiring high-performance computing infrastructure and colocation capabilities, targeting organizations seeking reliable, scalable blockchain and cryptocurrency mining operations.
Core Scientific is a North American leader in digital asset mining infrastructure, with a market capitalization of $5.5 billion and TTM revenue of $440.3 million. The company differentiates itself through vertically integrated data center operations and specialized expertise in blockchain infrastructure, positioning itself to capture value across both proprietary mining activities and third-party colocation services. With 325 employees and a geographically distributed footprint of owned facilities, Core Scientific maintains operational leverage in the evolving digital asset ecosystem.
What this transaction means for investors
There are plenty of reasons for an insider to sell shares. But the only reason someone buys shares is typically that they think the stock price will go up, which is a strong signal for shareholders. With the purchase of 6,000 shares, Crane has upped her stake to 71,348 shares. What's interesting about this purchase is that Crane picked up shares as the stock price rose rather than selling any shares to book profits, which, once again, is a sign of conviction in Core Scientific. Over the past 12 months, the stock price has been up 27.6%, compared with the S&P 500's 20% return over the same period.
Along with this insider purchase, another bullish signal for the stock is how analysts feel about it. According to CNN, of the 18 analysts who cover the Core Scientific, 94% rate it a buy, while only 6% rate it a hold. From that group, the median 12-month price target is $36, representing a massive 106.7% potential gain from today's price. The highest price target in that group is $55, representing a 215.9% profit, while even the lowest price target of $28 represents a 60.8% profit.
Should you buy stock in Core Scientific right now?
Before you buy stock in Core Scientific, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Core Scientific wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $446,157!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,377,357!*
Now, it’s worth noting Stock Advisor’s total average return is 984% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 3, 2026.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Core Scientific Director Elizabeth Crain Buys 6,000 Shares

Key Points
The transaction involved 10,000 shares executed at a weighted average price of $16.234 per share, resulting in a total value of ~$162,300 on August 31, 2026.
The executive traded shares equal to 0.52% of the stake held before the filing.
The sale consisted entirely of directly held shares, leaving the executive with ~1.9 million shares in a direct capacity.
The transaction was conducted under a Rule 10b5-1 trading plan, representing a pre-scheduled liquidity event.
Todd M. Duchene, Chief Legal and Administrative Officer at Core Scientific, Inc. (NASDAQ:CORZ), sold 10,000 shares of common stock on Aug. 31, 2026, according to a recent SEC Form 4 filing.
Transaction summary
Transaction value
$162,300
Shares sold
10,000
Post-transaction shares (directly held)
1,927,896
Post-transaction value
$31.4 million
Transaction value based on SEC Form 4 weighted average sale price ($16.23); post-transaction value based on Aug. 31, 2026 market close ($16.30).
Key questions
What is the significance of this transaction relative to the executive's total equity position?
The 10,000 shares sold represent 0.52% of the executive's prior holdings, which indicates a limited adjustment to the overall position. Following this transaction, the executive continues to hold 1,927,896 shares directly, a position valued at ~$31.4 million as of the Aug. 31, 2026, market close.
How does the timing of this sale relate to the executive's trading plan?
This sale was non-discretionary and was executed pursuant to a Rule 10b5-1 trading plan adopted on Dec. 5, 2025. These plans allow corporate insiders to establish a predetermined schedule for selling shares, providing a structured approach to liquidity that is independent of ongoing market developments or non-public information.
What is the recent performance context for the company's stock?
As of the transaction date on Aug. 31, 2026, the stock had delivered a one-year total return of 13.6%. The shares were priced at $16.07 as of the Sept. 1, 2026 market close, compared with a weighted-average execution price of $16.23 for this filing.
Company Overview
Share Price (as of market close 2026-09-02)
$16.81
Market Capitalization
$5.4 billion
Revenue (TTM)
$440.3 million
Net Income (TTM)
-$1.4 billion
Company Snapshot
Core Scientific operates digital asset mining facilities and provides colocation services for distributed ledger technology infrastructure, generating revenue through proprietary cryptocurrency mining operations and hosting services for blockchain network participants.
The company's business model leverages owned-and-operated data centers equipped with specialized computing hardware to process blockchain transactions in exchange for digital asset rewards, while simultaneously monetizing excess capacity through colocation and hosting services for enterprise clients.
Core Scientific serves enterprise customers and digital asset mining operations seeking reliable, scalable infrastructure for blockchain network participation and cryptocurrency mining activities in North America.
Core Scientific operates as a significant North American infrastructure provider in the digital asset and blockchain technology sector, with a market capitalization of $5.4 billion and TTM revenue of $440.3 million.
The company differentiates itself through vertically integrated operations combining proprietary mining activities with third-party colocation services, enabling operational leverage and diversified revenue streams.
Despite current profitability challenges, Core Scientific maintains substantial scale, with 325 employees, and a strategic position in the growing digital asset infrastructure market.
What this transaction means for investors
This sale shouldn't concern investors. It represented a small percentage of the officer's holdings in the company's stock. The office still retains a large stake of over 1.9 million shares following the sale.
Moreover, it was executed under a pre-scheduled plan, which insiders commonly use to execute transactions for personal financial reasons, regardless of the company's fundamentals.
Although Core Scientific's financials look messy right now, with large net losses reported, analysts anticipate robust growth in the coming years. Total contracted revenue for the company's data centers has reached $24 billion for about 1.1 gigawatts of billable capacity. Analysts expect revenue to grow at an annualized rate of 90% over the next two years.
Should you buy stock in Core Scientific right now?
Before you buy stock in Core Scientific, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Core Scientific wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $435,803!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,334,577!*
Now, it’s worth noting Stock Advisor’s total average return is 966% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 3, 2026.
John Ballard has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Core Scientific Executive Todd Duchene Sells 10,000 Shares

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Circle Internet Group Inc Class A (Symbol: CRCL), where a total of 122,386 contracts have traded so far, representing approximately 12.2 million underlying shares. That amounts to about 83.7% of CRCL's average daily trading volume over the past month of 14.6 million shares. Especially high volume was seen for the $95 strike call option expiring August 28, 2026, with 13,058 contracts trading so far today, representing approximately 1.3 million underlying shares of CRCL. Below is a chart showing CRCL's trailing twelve month trading history, with the $95 strike highlighted in orange:
Union Pacific Corp (Symbol: UNP) options are showing a volume of 19,753 contracts thus far today. That number of contracts represents approximately 2.0 million underlying shares, working out to a sizeable 80.9% of UNP's average daily trading volume over the past month, of 2.4 million shares. Especially high volume was seen for the $270 strike call option expiring September 18, 2026, with 6,129 contracts trading so far today, representing approximately 612,900 underlying shares of UNP. Below is a chart showing UNP's trailing twelve month trading history, with the $270 strike highlighted in orange:
And Core Scientific Inc (Symbol: CORZ) options are showing a volume of 95,609 contracts thus far today. That number of contracts represents approximately 9.6 million underlying shares, working out to a sizeable 79.8% of CORZ's average daily trading volume over the past month, of 12.0 million shares. Particularly high volume was seen for the $15 strike put option expiring October 02, 2026, with 14,839 contracts trading so far today, representing approximately 1.5 million underlying shares of CORZ. Below is a chart showing CORZ's trailing twelve month trading history, with the $15 strike highlighted in orange:
For the various different available expirations for CRCL options, UNP options, or CORZ options, visit StockOptionsChannel.com.
Further CRCL Research:

Notable Friday Option Activity: CRCL, UNP, CORZ

(RTTNews) - Core Scientific, Inc. (CORZ) has entered into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility. The proceeds of borrowings under the revolving credit facility may be used for general corporate purposes and working capital needs.
Jim Nygaard, CFO of Core Scientific, said: "The facilities are expected to release approximately $300 million of restricted cash, meaningfully improving our capital efficiency and financial flexibility as we pursue opportunities in a dynamic and rapidly evolving industry."

Core Scientific Enters Into $600 Mln Of Committed Senior Secured Credit Facilities

The NASDAQ 100 After Hours Indicator is up 4.7 to 29,626.51. The total After hours volume is currently 132,659,197 shares traded.
The following are the most active stocks for the after hours session:
NVIDIA Corporation (NVDA) is +1.57 at $219.12, with 5,586,968 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Jul 2026. The consensus EPS forecast is $2.01. As reported by Zacks, the current mean recommendation for NVDA is in the "buy range".
Tractor Supply Company (TSCO) is +0.2497 at $34.87, with 5,135,817 shares traded. TSCO's current last sale is 99.63% of the target price of $35.
Comcast Corporation (CMCSA) is -0.01 at $25.19, with 3,335,562 shares traded. CMCSA's current last sale is 83.97% of the target price of $30.
Hims & Hers Health, Inc. (HIMS) is -0.67 at $31.10, with 3,253,097 shares traded. HIMS's current last sale is 103.67% of the target price of $30.
GEN Restaurant Group, Inc. (GENK) is +0.8438 at $2.66, with 3,250,200 shares traded. As reported in the last short interest update the days to cover for GENK is 23.012247; this calculation is based on the average trading volume of the stock.
Core Scientific, Inc. (CORZ) is unchanged at $19.44, with 2,934,314 shares traded. As reported by Zacks, the current mean recommendation for CORZ is in the "buy range".
The Trade Desk, Inc. (TTD) is -0.07 at $13.32, with 2,618,784 shares traded. TTD's current last sale is 53.28% of the target price of $25.
PPL Corporation (PPL) is unchanged at $34.99, with 2,612,881 shares traded. As reported by Zacks, the current mean recommendation for PPL is in the "buy range".
Chevron Corporation (CVX) is -0.41 at $194.50, with 2,337,839 shares traded. As reported by Zacks, the current mean recommendation for CVX is in the "buy range".
Figma, Inc. (FIG) is -0.0783 at $25.31, with 2,012,122 shares traded. FIG's current last sale is 84.37% of the target price of $30.
Visa Inc. (V) is -1.17 at $360.15, with 1,942,020 shares traded. Over the last four weeks they have had 6 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2026. The consensus EPS forecast is $3.63. As reported by Zacks, the current mean recommendation for V is in the "buy range".
Transocean Ltd. (RIG) is +0.0197 at $5.74, with 1,739,753 shares traded. RIG's current last sale is 97.28% of the target price of $5.9.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

After Hours Most Active for Aug 10, 2026 : NVDA, TSCO, CMCSA, HIMS, GENK, CORZ, TTD, PPL, CVX, FIG, V, RIG

The NASDAQ 100 After Hours Indicator is up 39.45 to 28,816.25. The total After hours volume is currently 156,211,624 shares traded.
The following are the most active stocks for the after hours session:
Palantir Technologies Inc. (PLTR) is +11.35 at $137.00, with 10,023,068 shares traded. Smarter Analyst Reports: Thursday’s Pre-Market: Here’s What You Need to Know Before the Markets Opens
NVIDIA Corporation (NVDA) is +0.075 at $206.72, with 5,945,116 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Jul 2026. The consensus EPS forecast is $2.01. As reported by Zacks, the current mean recommendation for NVDA is in the "buy range".
Core Scientific, Inc. (CORZ) is +0.04 at $22.87, with 5,927,976 shares traded. As reported by Zacks, the current mean recommendation for CORZ is in the "buy range".
iShares Global Infrastructure ETF (IGF) is -0.0898 at $66.34, with 4,881,411 shares traded. This represents a 12.83% increase from its 52 Week Low.
Microsoft Corporation (MSFT) is -0.8884 at $486.76, with 4,345,235 shares traded. Over the last four weeks they have had 9 up revisions for the earnings forecast, for the fiscal quarter ending Sep 2026. The consensus EPS forecast is $4.67. As reported by Zacks, the current mean recommendation for MSFT is in the "buy range".
SoFi Technologies, Inc. (SOFI) is +0.01 at $18.04, with 4,259,795 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2026. The consensus EPS forecast is $0.2. SOFI's current last sale is 100.22% of the target price of $18.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

After Hours Most Active for Aug 3, 2026 : PLTR, NVDA, CORZ, IGF, MSFT, SOFI

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in SanDisk Corp (Symbol: SNDK), where a total volume of 188,007 contracts has been traded thus far today, a contract volume which is representative of approximately 18.8 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 136% of SNDK's average daily trading volume over the past month, of 13.8 million shares. Especially high volume was seen for the $1000 strike put option expiring July 31, 2026, with 4,894 contracts trading so far today, representing approximately 489,400 underlying shares of SNDK. Below is a chart showing SNDK's trailing twelve month trading history, with the $1000 strike highlighted in orange:
Eli Lilly (Symbol: LLY) options are showing a volume of 32,830 contracts thus far today. That number of contracts represents approximately 3.3 million underlying shares, working out to a sizeable 131.3% of LLY's average daily trading volume over the past month, of 2.5 million shares. Especially high volume was seen for the $1300 strike call option expiring July 31, 2026, with 1,798 contracts trading so far today, representing approximately 179,800 underlying shares of LLY. Below is a chart showing LLY's trailing twelve month trading history, with the $1300 strike highlighted in orange:
And Core Scientific Inc (Symbol: CORZ) saw options trading volume of 114,157 contracts, representing approximately 11.4 million underlying shares or approximately 109.6% of CORZ's average daily trading volume over the past month, of 10.4 million shares. Particularly high volume was seen for the $20 strike call option expiring July 31, 2026, with 20,580 contracts trading so far today, representing approximately 2.1 million underlying shares of CORZ. Below is a chart showing CORZ's trailing twelve month trading history, with the $20 strike highlighted in orange:
For the various different available expirations for SNDK options, LLY options, or CORZ options, visit StockOptionsChannel.com.
Further SNDK Research:
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Notable Tuesday Option Activity: SNDK, LLY, CORZ

Core Scientific, Inc. (CORZ) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +1,000.00%. A quarter ago, it was expected that this company would post a loss of $0.02 per share when it actually produced a loss of $0.1, delivering a surprise of -400%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Core Scientific, Inc., which belongs to the Zacks Financial - Miscellaneous Services industry, posted revenues of $164.2 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 20.38%. This compares to year-ago revenues of $78.63 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Core Scientific, Inc. shares have added about 42.4% since the beginning of the year versus the S&P 500's gain of 8.3%.
What's Next for Core Scientific, Inc.?
While Core Scientific, Inc. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Core Scientific, Inc. was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.02 on $167.2 million in revenues for the coming quarter and $0.08 on $619.65 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial - Miscellaneous Services is currently in the bottom 31% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Alerus (ALRS), another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on July 29.
This company is expected to post quarterly earnings of $0.78 per share in its upcoming report, which represents a year-over-year change of +8.3%. The consensus EPS estimate for the quarter has been revised 0.8% higher over the last 30 days to the current level.
Alerus' revenues are expected to be $76.85 million, up 1.9% from the year-ago quarter.
Should You Invest in Core Scientific, Inc. (CORZ)?
Before you invest in Core Scientific, Inc. (CORZ), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.
Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Core Scientific, Inc.

Options Strategies